Cannabis use in adolescents and anxiety symptoms and disorders: a systematic review and meta-analysis

References

• Cougle JR, Hakes JK, Macatee RJ, Chavarria J, Zvolensky MJ. Quality of life and risk of psychiatric disorders among regular users of alcohol, nicotine, and cannabis: an analysis of the national epidemiological survey on alcohol and related conditions (NESARC). J Psychiatr Res. 2015;66:135–41. doi:10.1016/j.jpsychires.2015.05.004.
   PubMed Web of Science ®Google Scholar
• Hasin DS, Kerridge BT, Saha TD, Huang B, Pickering R, Smith SM, Jung J, Zhang H, Grant BF. Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the national epidemiologic survey on alcohol and related conditions–III. Am J Psychiatry. 2016;173:588–99. doi:10.1176/appi.ajp.2015.15070907.
   PubMed Web of Science ®Google Scholar
• Kedzior KK, Laeber LT. A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population-a meta-analysis of 31 studies. Bmc Psychiatry. 2014;14:136. doi:10.1186/1471-244X-14-136.
   PubMed Web of Science ®Google Scholar
• Crippa JA, Zuardi AW, Martín‐Santos R, Bhattacharyya S, Atakan Z, McGuire P, Fusar‐Poli P. Cannabis and anxiety: a critical review of the evidence. Hum Psychopharmacol. 2009;24:515–23. doi:10.1002/hup.1048.
   PubMed Web of Science ®Google Scholar
• Lucatch AM, Coles AS, Hill KP, George TP. Cannabis and mood disorders. Curr Addict Rep. 2018;5:336–45. doi:10.1007/s40429-018-0214-y.
   PubMedGoogle Scholar
• McGee R, Williams S, Poulton R, Moffitt T. A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction. 2000;95:491–503. doi:10.1046/j.1360-0443.2000.9544912.x.
   PubMed Web of Science ®Google Scholar
• Dorard G, Berthoz S, Phan O, Corcos M, Bungener C. Affect dysregulation in cannabis abusers. Eur Child Adolesc Psychiatry. 2008;17:274–82. doi:10.1007/s00787-007-0663-7.
   PubMed Web of Science ®Google Scholar
• Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374:1383–1391. doi:10.1016/S0140-6736(09)61037-0.
   PubMed Web of Science ®Google Scholar
• Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov. 2004;3:771. doi:10.1038/nrd1495.
   PubMed Web of Science ®Google Scholar
• Hillard CJ, Weinlander KM, Stuhr K. Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience. 2012;204:207–229. doi:10.1016/j.neuroscience.2011.11.020.
   PubMed Web of Science ®Google Scholar
• Parsons LH, Hurd YL. Endocannabinoid signalling in reward and addiction. Nat Rev Neurosci. 2015;16:579–94. doi:10.1038/nrn4004.
   PubMed Web of Science ®Google Scholar
• Mechoulam R, Parker LA. The endocannabinoid system and the brain. annual review of psychology. Ann Rev Psychol. 2013;64:21–47. doi:10.1146/annurev-psych-113011-143739.
   PubMed Web of Science ®Google Scholar
• Grotenhermen F. Pharmacology of cannabinoids. Neuro Endocrinol Lett. 2004;25:14–23.
   PubMed Web of Science ®Google Scholar
• Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101–6. doi:10.1192/bjp.178.2.101.
   PubMed Web of Science ®Google Scholar
• D’Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu Y-T, Braley G, Gueorguieva R, Krystal JH. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology. 2004;29:1558. doi:10.1038/sj.npp.1300496.
   PubMed Web of Science ®Google Scholar
• Bergamaschi MM, Queiroz RHC, Chagas MHN, de Oliveira DCG, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology. 2011;36:1219. doi:10.1038/npp.2011.6.
   PubMed Web of Science ®Google Scholar
• Devinsky O, Cilio MR, Cross H, Fernandez‐Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras‐Aswad D, Notcutt WG, et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. 2014;55:791–802. doi:10.1111/epi.12631.
   PubMed Web of Science ®Google Scholar
• Lubman DI, Cheetham A, Yücel M. Cannabis and adolescent brain development. Pharmacology & Therapeutics. 2015;148:1–16. doi:10.1016/j.pharmthera.2014.11.009.
   PubMed Web of Science ®Google Scholar
• Silins E, Horwood LJ, Patton GC, Fergusson DM, Olsson CA, Hutchinson DM, Spry E, Toumbourou JW, Degenhardt L, Swift W, et al. Young adult sequelae of adolescent cannabis use: an integrative analysis. Lancet Psychiatry. 2014;1:286–293. doi:10.1016/S2215-0366(14)70307-4.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Coffey C, Romaniuk H, Swift W, Carlin JB, Hall WD, Patton GC. The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction. 2013;108:124–33. doi:10.1111/j.1360-0443.2012.04015.x.
   PubMed Web of Science ®Google Scholar
• Hayatbakhsh MR, et al. Cannabis and anxiety and depression in young adults: a large prospective study. J Am Acad Child Psy. 2007;46:408–417. doi:10.1097/chi.0b013e31802dc54d.
   Google Scholar
• Patton GC, et al. Cannabis use and mental health in young people: cohort study. BMJ. 2002;325:1195–1198. doi:10.1136/bmj.325.7374.1195.
   PubMed Web of Science ®Google Scholar
• Renard J, Krebs M-O, Le Pen G, Jay TM. Long-term consequences of adolescent cannabinoid exposure in adult psychopathology. Front Neurosci. 2014;8:361. doi:10.3389/fnins.2014.00361.
   PubMed Web of Science ®Google Scholar
• Copeland J, Rooke S, Swift W. Changes in cannabis use among young people: impact on mental health. Curr Opin Psychiatry. 2013;26:325–329. doi:10.1097/YCO.0b013e328361eae5.
   PubMed Web of Science ®Google Scholar
• Rotermann M, Langlois K. Prevalence and correlates of marijuana use in Canada, 2012. Ontario: Statistics Canada Ottawa; 2015.
   Google Scholar
• Canada GO Canadian Cannabis Survey 2017 - Summary 2017; https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2017-summary.html.
   Google Scholar
• Gobbi G, Atkin T, Zytynski T, Wang S, Askari S, Boruff J, Ware M, Marmorstein N, Cipriani A, Dendukuri N, et al. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis. JAMA Psychiarty. 2019;76:426–434. doi:10.1001/jamapsychiatry.2018.4500.
   PubMed Web of Science ®Google Scholar
• Xue S, Husain MI, Zhao H, Ravindran AV. Cannabis Use and Prospective Long-Term Association with Anxiety: a systematic review and meta-analysis of longitudinal studies: usage du cannabis et association prospective à long terme avec l’anxiété: une revue systématique et une méta-analyse d’études longitudinales. Can J Psychiatry. 2021;66:126–38. doi:10.1177/0706743720952251.
   PubMed Web of Science ®Google Scholar
• George TP, Hill KP, Vaccarino FJ. Cannabis legalization and psychiatric disorders: caveat “hemp-tor”. Can J Psychiatry. 2018;63:447–50. doi:10.1177/0706743718762387.
   PubMed Web of Science ®Google Scholar
• Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269. doi:10.7326/0003-4819-151-4-200908180-00135.
   PubMed Web of Science ®Google Scholar
• Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007;7:1–6. doi:10.1186/1472-6947-7-16.
   PubMed Web of Science ®Google Scholar
• Schünemann H, et al. The GRADE approach and Bradford Hill’s criteria for causation. J Epidemiol Commun H. 2011;65:392–395. doi:10.1136/jech.2010.119933.
   PubMed Web of Science ®Google Scholar
• Peterson J, Welch V, Losos M, Tugwell PJ. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011.
   Google Scholar
• Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I² index? Psychol Methods. 2006;11:193. doi:10.1037/1082-989X.11.2.193.
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Lynskey MT, Horwood LJ. The short-term consequences of early onset cannabis use. J Abnorm Child Psychol. 1996;24:499–512. doi:10.1007/BF01441571.
   PubMed Web of Science ®Google Scholar
• Windle M, Wiesner M. Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes. Develop Psychopathol. 2004;16:1007–27. doi:10.1017/S0954579404040118.
   PubMed Web of Science ®Google Scholar
• Zvolensky MJ, Lewinsohn P, Bernstein A, Schmidt NB, Buckner JD, Seeley J, Bonn-Miller MO. Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder. J Psychiatr Res. 2008;42:1017–23. doi:10.1016/j.jpsychires.2007.10.012.
   PubMed Web of Science ®Google Scholar
• Hengartner MP, Angst J, Ajdacic-Gross V, Rössler W. Cannabis use during adolescence and the occurrence of depression, suicidality and anxiety disorder across adulthood: findings from a longitudinal cohort study over 30 years. J Affect Disord. 2020;272:98–103. doi:10.1016/j.jad.2020.03.126.
   PubMed Web of Science ®Google Scholar
• Chan GCK, Becker D, Butterworth P, Hines L, Coffey C, Hall W, Patton G. Young-adult compared to adolescent onset of regular cannabis use: a 20-year prospective cohort study of later consequences. Drug Alcohol Rev. 2021;40:627–36. doi:10.1111/dar.13239.
   PubMed Web of Science ®Google Scholar
• Mustonen A, Hielscher E, Miettunen J, Denissoff A, Alakokkare AE, Scott JG, Niemelä S. Adolescent cannabis use, depression and anxiety disorders in the Northern Finland birth cohort 1986. BJPsych Open. 2021;7:e137.
   PubMed Web of Science ®Google Scholar
• Brook JS, Lee JY, Brown EN, Finch SJ, Brook DW. Developmental trajectories of marijuana use from adolescence to adulthood: personality and social role outcomes. Psychol Rep. 2011;108:339–57. doi:10.2466/10.18.PR0.108.2.339-357.
   PubMed Web of Science ®Google Scholar
• Guttmannova K, Kosterman R, White HR, Bailey JA, Lee JO, Epstein M, Jones TM, Hawkins JD. The association between regular marijuana use and adult mental health outcomes. Drug Alcohol Depen. 2017;179:109–16. doi:10.1016/j.drugalcdep.2017.06.016.
   PubMed Web of Science ®Google Scholar
• Otten R, Huizink AC, Monshouwer K, Creemers HE, Onrust S. Cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene. Addict Biol. 2017;22:1081–89. doi:10.1111/adb.12372.
   PubMed Web of Science ®Google Scholar
• Meier MH, Beardslee J, Pardini D. Associations between recent and cumulative cannabis use and internalizing problems in boys from adolescence to young adulthood. J Abnorm Child Psychol. 2020;48:1–12. doi:10.1007/s10802-020-00641-8.
   PubMed Web of Science ®Google Scholar
• London-Nadeau K, Rioux C, Parent S, Vitaro F, Côté SM, Boivin M, Tremblay RE, Séguin JR, Castellanos-Ryan N. Longitudinal associations of cannabis, depression, and anxiety in heterosexual and LGB adolescents. J Abnorm Psychol. 2021;130:333. doi:10.1037/abn0000542.
   PubMed Web of Science ®Google Scholar
• Duncan MJ, Patte KA, Leatherdale ST. Hit the chronic … physical activity: are cannabis associated mental health changes in adolescents attenuated by remaining active? Soc Psychiatry Psychiatr Epidemiol. 2021;56:141–52. doi:10.1007/s00127-020-01900-1.
   PubMed Web of Science ®Google Scholar
• Duperrouzel J, Hawes SW, Lopez-Quintero C, Pacheco-Colón I, Comer J, Gonzalez R. The association between adolescent cannabis use and anxiety: a parallel process analysis. Addict Behav. 2018;78:107–13. doi:10.1016/j.addbeh.2017.11.005.
   PubMed Web of Science ®Google Scholar
• Otten R, Engels RC. Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene. Addict Biol. 2013;18:826–35. doi:10.1111/j.1369-1600.2011.00380.x.
   PubMed Web of Science ®Google Scholar
• Nordquist N, Oreland L. Serotonin, genetic variability, behaviour, and psychiatric disorders-a review. Ups J Med Sci. 2010;115:2–10. doi:10.3109/03009730903573246.
   PubMed Web of Science ®Google Scholar
• Brook JS, Cohen P, Brook DW. Longitudinal study of co-occurring psychiatric disorders and substance use. J Am Acad Child Psy. 1998;37:322–330. doi:10.1097/00004583-199803000-00018.
   Google Scholar
• Gage S, Hickman M, Heron J, Munafò MR, Lewis G, Macleod J, Zammit S. Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the avon longitudinal study of parents and children. Psychol Med. 2014;44:3435–44. doi:10.1017/S0033291714000531.
   PubMed Web of Science ®Google Scholar
• Gage SH, Hickman M, Heron J, Munafò MR, Lewis G, Macleod J, Zammit S. Associations of cannabis and cigarette use with depression and anxiety at age 18: findings from the avon longitudinal study of parents and children. PLoS ONE. 2015;10:e0122896. doi:10.1371/journal.pone.0122896.
   PubMed Web of Science ®Google Scholar
• Blest-Hopley G, Colizzi M, Giampietro V, Bhattacharyya S. Is the adolescent brain at greater vulnerability to the effects of cannabis? A narrative review of the evidence. Front Psychiatry. 2020;11:859. doi:10.3389/fpsyt.2020.00859.
   PubMed Web of Science ®Google Scholar
• Pabon E, Rockwood F, Norman GJ, de Wit H. Acute effects of oral delta‐9‐tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects. Psychophysiology. 2022;59:e13955. doi:10.1111/psyp.13955.
   PubMed Web of Science ®Google Scholar
• Crippa JAS, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, Martin-Santos R, Simões MV, Bhattacharyya S, Fusar-Poli P, Atakan Z, et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol. 2011;25:121–30. doi:10.1177/0269881110379283.
   PubMed Web of Science ®Google Scholar
• Knapp AA, Lee DC, Borodovsky JT, Auty SG, Gabrielli J, Budney AJ. Emerging trends in cannabis administration among adolescent cannabis users. J Adolesc Health. 2019;64:487–93. doi:10.1016/j.jadohealth.2018.07.012.
   PubMed Web of Science ®Google Scholar
• Lowe DJ, Sasiadek JD, Coles AS, George TP. Cannabis and mental illness: a review. Eur Arch Psychiatry Clin Neurosci. 2019;269:107–20. doi:10.1007/s00406-018-0970-7.
   PubMed Web of Science ®Google Scholar
• Rubino T, Parolaro D. Sex-dependent vulnerability to cannabis abuse in adolescence. Front Psychiatry. 2015;6:56. doi:10.3389/fpsyt.2015.00056.
   PubMed Web of Science ®Google Scholar
• Dunbar MS, Siconolfi D, Rodriguez A, Seelam R, Davis JP, Tucker JS, D’Amico EJ. Alcohol use and cannabis use trajectories and sexual/gender minority disparities in young adulthood. Psychol Addict Behav. 2022;36:477–90. doi:10.1037/adb0000806.
   PubMed Web of Science ®Google Scholar
• Cyrus E, Coudray MS, Kiplagat S, Mariano Y, Noel I, Galea JT, Hadley D, Dévieux JG, Wagner E. A review investigating the relationship between cannabis use and adolescent cognitive functioning. Curr Opin Psychol. 2021;38:38–48. doi:10.1016/j.copsyc.2020.07.006.
   PubMed Web of Science ®Google Scholar
• Mereish EH, Fish JN, Watson RJ. Intersectional minority stress and alcohol, tobacco, and cannabis use among sexual and gender minority adolescents of color: moderating role of family support. LGBT Health. 2023;10:18–25. doi:10.1089/lgbt.2021.0430.
   PubMed Web of Science ®Google Scholar
• Jardin C, Paulus DJ, Garey L, Kauffman B, Bakhshaie J, Manning K, Mayorga NA, Zvolensky MJ. Towards a greater understanding of anxiety sensitivity across groups: the construct validity of the anxiety sensitivity index-3. Psychiatry Res. 2018;268:72–81. doi:10.1016/j.psychres.2018.07.007.
   PubMed Web of Science ®Google Scholar